Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uro-Vaxom for UTI Prevention in Neurogenic Bladder
NCT02591901Phase 2Completed
- Sponsor
- Buckinghamshire Healthcare NHS Trust
- Start
- Apr 2018
- Primary completion
- Aug 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of OM-89 in urinary tract infection (UTI), sponsored by Buckinghamshire Healthcare NHS Trust. Started Apr 2018; status: completed.
02
Drugs
OM-89
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT02591901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02591901.